MBP and hepatocellular carcinoma: Hokuto et al. [20] compared the perioperative outcomes of patients who received or did not receive MBP before liver resection, and they manifested that the use of MBP has no significant effect on short-term outcomes after liver resection in patients with hepatocellular carcinoma (HCC); therefore, liver surgery can omit MBP.